Lichen planus is a common, disease affecting the skin and mucous membranes of the mouth. It usually affects middle-aged women. The condition causes itchy, purple-colored bumps or scaly patches on the skin. Lichen planus can also affect the nails, scalp, genitals, and inside of the mouth.
There is no known cause for Lichen Planus Market, but it's believed to be an autoimmune reaction. Symptoms range from mild to severe itching, discomfort of soreness, and discolored skin lesions. Topical corticosteroids are considered first-line therapy for LP on the skin and genitals. Second-line therapies include topical calcineurin inhibitors, topical retinoids, phototherapy, immunomodulatory drugs, and immunosuppressants.
The Global Lichen Planus Market is estimated to be valued at USD 150.1 million in 2024 and is expected to reach USD 251.2 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
Key players operating in the lichen planus therapeutics are Pfizer Inc., Novartis AG, Bristol Myers Squibb, Merck & Co., Inc., Amgen Inc.
Lichen planus commonly affects fingers, wrists, ankles and lower legs. It most often appears as small, flat-topped, violaceous papules and plaques with fine whitish scales.Treatment aims to relieve symptoms such as itching and soreness. Topical corticosteroids are usually first-line treatment. Second-line options include topical calcineurin inhibitors, phototherapy, systemic immunosuppressants for severe disease. The increasing prevalence of autoimmune disorders coupled with weak immune system among individuals have boosted the growth of the lichen planus therapeutics market.
Key opportunities in the lichen planus therapeutics market include developing new formulations to increase efficacy and reduce side effects of existing drugs. Also, focusing on developing biologics and targeted therapies for treatment of lichen planus. Emergence of biosimilars would also present an opportunity for cost saving. The increasing R&D investments by key players to develop novel therapies such as biologics for treatment of lichen planus provide immense growth opportunity. Furthermore, growth of healthcare infrastructure and rising healthcare expenditures in developing economies provide huge growth opportunities.
Market drivers: The increasing prevalence of lichen planus across the globe is a major factor driving the lichen planus therapeutics market. According to estimates, the global prevalence of lichen planus is estimated around 0.22-5% among adults.
Market restraints: High costs of targeted therapies and biologics for treatment of lichen planus limits their widespread use. Also, lack of approved drugs in developing countries acts as restraint for market growth.
Segment Analysis The lichen planus market can be segmented based on type, treatment, end-user, and distribution channel. Based on type, the segment is divided into hypertrophic, atrophic, actinic, bullous, and others. The hypertrophic segment dominates the market as this type is commonly diagnosed type of lichen planus. This type causes purple or whitish raised bumps or lesions on the skin which causes itching. Based on treatment, the market is categorized into corticosteroids, antihistamines, retinoids, aloe vera, and others. The corticosteroids segment holds the largest share as they are the first line of treatment for lichen planus and effectively reduces itching and rashes. Topical and oral corticosteroids are commonly prescribed for lichen planus treatment.
Global Analysis The regional analysis of the lichen planus market covers North America, Europe, Asia Pacific, South America, and Middle East & Africa. Europe dominates the global market, owing to the rising older population prone to lichen planus. According to the European Academy of Dermatology and Venereology, lichen planus affects 0.22% to 2.6% of the general population in Europe. Asia Pacific is expected to witness the highest growth over the forecast period. This is attributed to the large patient pool, increasing awareness regarding lichen planus diagnosis and treatment, improving healthcare infrastructure, and growing medical tourism in countries such as India and China.
Get this Report in Japanese Language: 扁平苔癬マーケット
Get this Report in Korean Language: 리켄 플라누스 마켓
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
For people suffering from oral lichen planus, simply chewing on sage can be a very successful Natural Treatment for Lichen Planus that can help take away some of the pain.
If you find chewing on sage is not easy, then you can prepare a tea with dried sage and drink that up instead.
People have been using oats to treat skin disease and to decrease skin inflammation.
It has anti-oxidant properties that decrease irritation and soothe painful lesions.
Oats are an effective Natural Remedy for Lichen Planus.
Lichen Planus Herbal Treatment at home by Herbal Care Products.
Erosive Lichen Planus Symptoms, Skin Scalp Causes, mouth, tongue, nails etc.
Cure of lp disease is Plenical for patients.
Lichen Planus Herbal Treatment to improve symptoms caused by lichen planus.
Natural Remedies for Lichen Planus to improve symptoms caused by lichen planus.
Herbal Treatment for Lichen Planus read the Symptoms and Causes.
Natural Remedies for Lichen Planus used to reduce the pain.
For making one of the helpful Natural Remedies for Lichen Planus you should add four ounces of Aloe Vera gel and one tablespoon of coconut oil.
You should mix it well.
